Federal drug program officials talked about the effectiveness of treatment programs. The Substance Abuse Administration’s funding is up for renewal this year. Officials of private drug treatment programs also testified about drug and mental illness treatment. Topics included treatment costs, recidivism, accountability and measuring treatment performance.